Clinical Trial Update: Bone Regeneration With Mesenchymal Stem Cells [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bone regeneration with mesenchymal stem cells for mandibular fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mandibular Fracture

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Mandibular Fractures | Phase 3 | Status: COMPLETED